{'52WeekChange': -0.092651844,
 'SandP52WeekChange': None,
 'address1': '21925 West Field Parkway',
 'address2': 'Suite 235',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 5.84,
 'askSize': 800,
 'averageDailyVolume10Day': 78100,
 'averageVolume': 132109,
 'averageVolume10days': 78100,
 'beta': None,
 'beta3Year': None,
 'bid': 5.35,
 'bidSize': 1000,
 'bookValue': 0.512,
 'category': None,
 'circulatingSupply': None,
 'city': 'Deer Park',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 5.79,
 'dayLow': 5.55,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -5.627,
 'enterpriseToRevenue': 196.594,
 'enterpriseValue': 109699528,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '510 937 0262',
 'fiftyDayAverage': 5.52,
 'fiftyTwoWeekHigh': 7.7,
 'fiftyTwoWeekLow': 2.5,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 10564354,
 'forwardEps': -0.6,
 'forwardPE': -9.349999,
 'fromCurrency': None,
 'fullTimeEmployees': 17,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.33173,
 'heldPercentInstitutions': 0.23096001,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/etonpharma.com',
 'longBusinessSummary': 'Eton Pharmaceuticals, Inc., a specialty '
                        'pharmaceutical company, focuses on developing and '
                        'commercializing pharmaceutical products. The company '
                        'offers Biorphen, a phenylephrine hydrochloride '
                        'injection for the treatment of clinically important '
                        'hypotension resulting primarily from vasodilation in '
                        'the setting of anesthesia. It also develops EM-100, '
                        'an ophthalmic product for the treatment of allergic '
                        'conjunctivitis; ET-203, which is injectable product '
                        'candidates for use in the hospital setting; ET-103, '
                        'an oral liquid product candidate for hypothyroidism; '
                        'ET-101 and ET-104, which are oral liquid product '
                        'candidates for neurological indications; DS-300 and '
                        'DS-100, which are injectable product candidates; and '
                        'ET-105, a lamotrigine for oral suspension. Eton '
                        'Pharmaceuticals, Inc. was founded in 2017 and is '
                        'based in Deer Park, Illinois.',
 'longName': 'Eton Pharmaceuticals, Inc.',
 'market': 'us_market',
 'marketCap': 117344376,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_435353222',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -19959000,
 'nextFiscalYearEnd': 1640908800,
 'open': 5.68,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '847 787 7361',
 'previousClose': 5.68,
 'priceHint': 2,
 'priceToBook': 10.957031,
 'priceToSalesTrailing12Months': 210.29459,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 5.79,
 'regularMarketDayLow': 5.55,
 'regularMarketOpen': 5.68,
 'regularMarketPreviousClose': 5.68,
 'regularMarketPrice': 5.68,
 'regularMarketVolume': 54792,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 20917000,
 'sharesPercentSharesOut': 0.0269,
 'sharesShort': 563456,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 290358,
 'shortName': 'Eton Pharmaceuticals, Inc.',
 'shortPercentOfFloat': 0.0476,
 'shortRatio': 3,
 'startDate': None,
 'state': 'IL',
 'strikePrice': None,
 'symbol': 'ETON',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.114,
 'twoHundredDayAverage': 5.3583455,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'fbcd977f-686a-3d1e-ae47-b3ae800e35f4',
 'volume': 54792,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.etonpharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '60010-7208'}